Patents Assigned to Research & Diagnostics Systems, Inc.
-
Patent number: 9096888Abstract: A method of detecting sulfotransferase activity including conducting a first reaction comprising, measuring free phosphate produced by the first reaction, and comparing the measured free phosphate to a free phosphate standard curve or equation or to a free phosphate level obtained in a separate reaction. The first reaction includes combining the sulfotransferase, Golgi-resident PAP-phosphatase (gPAPP), a 5?-nucleotidase, a substrate of the sulfotransferase, and 3?-phosphoadenosine-5?-phosphosulfate (PAPS) under conditions to produce 3?-phosphoadenosine-5?-phosphate (PAP).Type: GrantFiled: July 23, 2014Date of Patent: August 4, 2015Assignee: Research & Diagnostics Systems, Inc.Inventor: Zhengliang L. Wu
-
Patent number: 8815529Abstract: Assays and methods for detecting and/or quantifying activity of a test sulfotransferase comprising by releasing a free phosphate from the PAP produced by the sulfotransferase reaction and detecting the free phosphate. The assay can includes gPAPP, a free phosphate detector and an optional control sulfotransferase. The method includes combining a test sulfotransferase with the substrate of the sulfotransferase, PAPS and gPAPP and detecting the free phosphate. The level of free phosphate directly correlates to the activity of the sulfotransferase. The assay and methods can be used to screen agents for their effect upon sulfotransferase activity.Type: GrantFiled: May 23, 2011Date of Patent: August 26, 2014Assignee: Research & Diagnostics Systems, Inc.Inventor: Zhengliang L. Wu
-
Publication number: 20140080161Abstract: Assays and methods for detecting and quantifying the activity of a test kinase. The assay includes a nucleotide phosphatase at least ten times more active on ADP than on ATP and a free phosphate detector. The assay may also include a control kinase and/or ATP. Methods of the invention include combining a test kinase, a substrate of the test kinase, and a known quantity of ATP under conditions to produce ADP, combining the produced ADP with a phosphatase specific for ADP, and measuring free phosphate. The amount of phosphate produced directly correlates to the activity of the kinase.Type: ApplicationFiled: September 14, 2010Publication date: March 20, 2014Applicant: RESEARCH AND DIAGNOSTIC SYSTEMS, INC.Inventor: Zhenliang L. Wu
-
Publication number: 20130065262Abstract: A kit for detecting or measuring glycosyltransferase activity including a first reagent comprising a phosphatase and a second reagent comprising a free phosphate detector, and method of detecting and measuring glycosyltransferase activity. A sugar donor, an acceptor substrate, a glycosyltransferase enzyme and a phosphatase are combined and the amount of free phosphate present in the product is measured and used to calculate the activity of the glycosyltransferase enzyme.Type: ApplicationFiled: May 24, 2010Publication date: March 14, 2013Applicant: RESEARCH AND DIAGNOSTIC SYSTEMS, INC.Inventor: Zhenliang L. Wu
-
Publication number: 20120301909Abstract: Assays and methods for detecting and/or quantifying activity of a test sulfotransferase comprising by releasing a free phosphate from the PAP produced by the sulfotransferase reaction and detecting the free phosphate. The assay can includes gPAPP, a free phosphate detector and an optional control sulfotransferase. The method includes combining a test sulfotransferase with the substrate of the sulfotransferase, PAPS and gPAPP and detecting the free phosphate. The level of free phosphate directly correlates to the activity of the sulfotransferase. The assay and methods can be used to screen agents for their effect upon sulfotransferase activity.Type: ApplicationFiled: May 23, 2011Publication date: November 29, 2012Applicant: RESEARCH AND DIAGNOSTIC SYSTEMS, INC.Inventor: Zhenliang L. WU
-
Patent number: 7855051Abstract: A method of detecting the presence of mycoplasma in a sample and a mycoplasm detection kit. A sample is contacted with a first and a second oligonucleotide probe, wherein the first and second oligonucleotide probes are substantially complementary to portions of a 16S ribosomal subunit of at least one mycoplasma species. The first probe may be labeled with a capture ligand. The second probe may be labeled with a first component of a detection system.Type: GrantFiled: September 12, 2006Date of Patent: December 21, 2010Assignee: Research & Diagnostic Systems, Inc.Inventors: Michael G Anderson, Jackie A. Ernst, Kim M. Herman-Hatten, James J. Rivard, Paul Younge
-
Patent number: 7749757Abstract: Methods and compositions for stabilizing tissues, cells, and cell components such that desired antigenic sites, light scatter properties and cellular morphology are preserved for a useful period of time. The stabilizing solution includes glycine, lysine and formaldehyde.Type: GrantFiled: August 15, 2007Date of Patent: July 6, 2010Assignee: Research & Diagnostic Systems, Inc.Inventors: Frank Mortari, Paige M Johnson, Alan M Johnson
-
Patent number: 7267980Abstract: Methods and compositions for stabilizing tissues, cells, and cell components such that desired antigenic sites, light scatter properties and cellular morphology are preserved for a useful period of time. The stabilizing solution includes glycine, lysine and formaldehyde.Type: GrantFiled: April 4, 2003Date of Patent: September 11, 2007Assignee: Research & Diagnostic Systems, Inc.Inventors: Frank Mortari, Paige Marie Pulvermacher, Alan M. Johnson
-
Patent number: 6759246Abstract: A control composition, and method of preparing a control composition, that includes stabilized, mammalian granulocytes having altered physical properties so that the granulocytes function as a human lymphocyte analogs when used on an automated blood cell analyzer.Type: GrantFiled: November 30, 2001Date of Patent: July 6, 2004Assignee: Research & Diagnostic Systems, Inc.Inventor: Mark Collins
-
Patent number: 6444471Abstract: A control composition, and method of preparing a control composition, that includes stabilized, maturation-arrested reticulocytes, and a complete blood count base including mature erythrocytes, stabilized white cells and stabilized platelets, or analogs thereof.Type: GrantFiled: October 18, 1999Date of Patent: September 3, 2002Assignee: Research & Diagnostic Systems, Inc.Inventor: Alan M. Johnson
-
Patent number: 5945340Abstract: A pre-determined concentration of stabilized, maturation-arrested porcine reticulocytes in a red blood cell base, useful as a reticulocyte control composition. The composition can be provided in the form of a concentrated reticulocyte composition, to be diluted to a desired final reticulocyte concentration at the time of use. The composition can also be provided in the form of a diluted, ready-to-use control composition. Also included is a method of preparing such a composition, the method involving sequential steps of forming and sedimenting Rouleaux bodies.Type: GrantFiled: January 11, 1999Date of Patent: August 31, 1999Assignee: Research & Diagnostics Systems, Inc.Inventors: Ralph T. Francis, Alan M. Johnson
-
Patent number: 5858789Abstract: A pre-determined concentration of stabilized, maturation-arrested porcine reticulocytes in a red blood cell base, useful as a reticulocyte control composition. The composition can be provided in the form of a concentrated reticulocyte composition, to be diluted to a desired final reticulocyte concentration at the time of use. The composition can also be provided in the form of a diluted, ready-to-use control composition. Also included is a method of preparing such a composition, the method involving sequential steps of forming and sedimenting Rouleaux bodies.Type: GrantFiled: April 6, 1998Date of Patent: January 12, 1999Assignee: Research & Diagnostic Systems, inc.Inventors: Ralph T. Francis, Alan M. Johnson
-
Patent number: 5736402Abstract: A pre-determined concentration of stabilized, maturation-arrested porcine reticulocytes in a red blood cell base, useful as a reticulocyte control composition. The composition can be provided in the form of a concentrated reticulocyte composition, to be diluted to a desired final reticulocyte concentration at the time of use. The composition can also be provided in the form of a diluted, ready-to-use control composition. Also included is a method of preparing such a composition, the method involving sequential steps of forming and sedimenting Rouleaux bodies.Type: GrantFiled: August 12, 1996Date of Patent: April 7, 1998Assignee: Research & Diagnostics Systems, Inc.Inventors: Ralph T. Francis, Alan M. Johnson
-
Patent number: 5627033Abstract: A vector system that allows the rapid and effective screening of recombinant constructs. The vector system includes a marker protein useful for identifying transfected cell lines, wherein the promoter used to express the marker protein has be substantially weakened in comparison to its corresponding wild type form.Type: GrantFiled: March 28, 1995Date of Patent: May 6, 1997Assignee: Research & Diagnostics Systems, Inc.Inventors: John M. Smith, John E. Humphrey, Monica L. Tsang, James A. Weatherbee